These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2680552)

  • 1. Epidemiologic significance of immunity in vivax malaria.
    Clyde DF
    Epidemiol Rev; 1989; 11():109-25. PubMed ID: 2680552
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity and malaria in man.
    McGregor IA
    Trop Doct; 1974 Jul; 4(3):104-9. PubMed ID: 4212067
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of human malaria transmission by anti-gamete transmission blocking immunity.
    de Zoysa AP; Herath PR; Abhayawardana TA; Padmalal UK; Mendis KN
    Trans R Soc Trop Med Hyg; 1988; 82(4):548-53. PubMed ID: 3076711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of malaria.
    Bruce-Chwatt LJ
    J Parasitol; 1970 Aug; 56(4):552-5. PubMed ID: 4991616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of antibodies to vivax-malaria by ELISA using in vitro cultured erythrocytic Plasmodium cynomolgi as antigen].
    Wang XZ; Li ST; Xi YH; Ye JS; Zhou ZX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(1):29-31. PubMed ID: 3289786
    [No Abstract]   [Full Text] [Related]  

  • 6. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria.
    Goonewardene R; Carter R; Gamage CP; Del Giudice G; David PH; Howie S; Mendis KN
    Eur J Immunol; 1990 Jun; 20(6):1387-91. PubMed ID: 2196178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanisms of acquired immunity in infections with Plasmodium vivax. Fluorescent antibody technics in the complex of cyto-sero-chemical tests of the blood system during the process of immunogenesis].
    Bona C; Ciplea AG; Ianco L; Negulici EB; Constantinesco P
    Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):749-62. PubMed ID: 5318885
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of IHA and ELISA in seroepidemiology of malaria.
    Kumar R; Rao SN; Ansari MA; Razdan RK; Srivastava A; Sharma VP
    Indian J Malariol; 1986 Dec; 23(2):75-80. PubMed ID: 3552760
    [No Abstract]   [Full Text] [Related]  

  • 9. A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants.
    Sehgal VM; Siddjiqui WA; Alpers MP
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():105-6. PubMed ID: 2696154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte migration inhibition test in human Plasmodium vivax malaria.
    Ravindran B; Sharma BK; Pillai CR; Hussain QZ
    J Trop Med Hyg; 1983 Dec; 86(6):207-11. PubMed ID: 6368860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel in vitro model reveals distinctive modulatory roles of Plasmodium falciparum and Plasmodium vivax on naïve cell-mediated immunity.
    Chitsanoor S; Somsri S; Panburana P; Mungthin M; Ubalee R; Emyeam M; Jongwutiwes S; Sattabongkot J; Udomsangpetch R
    Malar J; 2017 Mar; 16(1):131. PubMed ID: 28347310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil.
    Cerutti C; Boulos M; Coutinho AF; Hatab Mdo C; Falqueto A; Rezende HR; Duarte AM; Collins W; Malafronte RS
    Malar J; 2007 Mar; 6():33. PubMed ID: 17371598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation of fluorescent antibodies during human malaria caused by malaria therapy with Plasmodium vivax].
    Garin JP; Ambroise-Thomas P; Truong TK; Saliou P
    Bull World Health Organ; 1971; 44(5):689-99. PubMed ID: 4946338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malaria prevention. Chemotherapy and immune prophylaxis. 3. Immune response of infected organism. Perspectives of Malaria prevention].
    Wagner WH
    Arzneimittelforschung; 1986 Mar; 36(3):409-15. PubMed ID: 2423092
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure.
    Changrob S; Han JH; Ha KS; Park WS; Hong SH; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):348. PubMed ID: 28830553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates.
    Premawansa S; Peiris JS; Perera KL; Ariyaratne G; Carter R; Mendis KN
    J Immunol; 1990 Jun; 144(11):4376-83. PubMed ID: 1692862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil.
    Kremsner PG; Neifer S; Zotter GM; Bienzle U; Rocha RM; Maracic M; Clavijo P; Nussenzweig RS; Cochrane AH
    Trans R Soc Trop Med Hyg; 1992; 86(1):23-7. PubMed ID: 1373529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eroding the resistance of Duffy negativity to invasion by Plasmodium vivax?
    Pasvol G
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):953-4. PubMed ID: 17658565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phagocytosis of a merozoite in a blood smear from a patient with Plasmodium vivax malaria].
    Le Fichoux Y; Marty P; Dellamonica P; Doucet J
    Bull Soc Pathol Exot Filiales; 1986; 79(3):350-1. PubMed ID: 3533294
    [No Abstract]   [Full Text] [Related]  

  • 20. Sero-epidemiological survey of malaria by immunofluorescence in Pakistan (District Gujranwala-Punjab).
    Lari FA; Burney MI; Rab MA
    J Pak Med Assoc; 1991 Sep; 41(9):216-9. PubMed ID: 1744969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.